1107 related articles for article (PubMed ID: 19718606)
1. [Pulmonary hypertension in COPD and interstitial lung diseases].
Markart P; Ghofrani HA; Grimminger F; Günther A
Dtsch Med Wochenschr; 2009 Aug; 134 Suppl 5():S164-6. PubMed ID: 19718606
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary hypertension in chronic obstructive pulmonary disease and interstitial lung diseases.
Weitzenblum E; Chaouat A; Canuet M; Kessler R
Semin Respir Crit Care Med; 2009 Aug; 30(4):458-70. PubMed ID: 19634085
[TBL] [Abstract][Full Text] [Related]
3. [Pulmonary hypertension in lung diseases].
Behr J
Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S196-8. PubMed ID: 18814095
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary hypertension in chronic lung diseases.
Seeger W; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs S; Martinez FJ; Semigran MJ; Simonneau G; Wells AU; Vachiéry JL
J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D109-16. PubMed ID: 24355635
[TBL] [Abstract][Full Text] [Related]
5. [Dana Point: what is new in the treatment of pulmonary hypertension?].
Hoeper MM; Ghofrani HA; Grimminger F; Rosenkranz S
Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S191-5. PubMed ID: 18814094
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary hypertension in chronic obstructive pulmonary disease.
Weitzenblum E; Chaouat A; Kessler R
Pneumonol Alergol Pol; 2013; 81(4):390-8. PubMed ID: 23744170
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease.
Launay D; Mouthon L; Hachulla E; Pagnoux C; de Groote P; Remy-Jardin M; Matran R; Lambert M; Queyrel V; Morell-Dubois S; Guillevin L; Hatron PY
J Rheumatol; 2007 May; 34(5):1005-11. PubMed ID: 17444586
[TBL] [Abstract][Full Text] [Related]
8. Sildenafil therapy in secondary pulmonary hypertension: Is there benefit in prolonged use?
Chapman TH; Wilde M; Sheth A; Madden BP
Vascul Pharmacol; 2009; 51(2-3):90-5. PubMed ID: 19386283
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary hypertension in COPD: a review and consideration of the role of arterial vasodilators.
Burger CD
COPD; 2009 Apr; 6(2):137-44. PubMed ID: 19378227
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary hypertension in patients with interstitial lung diseases.
Ryu JH; Krowka MJ; Pellikka PA; Swanson KL; McGoon MD
Mayo Clin Proc; 2007 Mar; 82(3):342-50. PubMed ID: 17352370
[TBL] [Abstract][Full Text] [Related]
11. [Update: Current clinical developments in pulmonary hypertension].
Dumitrescu D; Ghofrani HA; Grimminger F; Hoeper MM; Rosenkranz S
Dtsch Med Wochenschr; 2009 Aug; 134 Suppl 5():S160-3. PubMed ID: 19718605
[TBL] [Abstract][Full Text] [Related]
12. Cardiopulmonary exercise test characteristics in patients with chronic obstructive pulmonary disease and associated pulmonary hypertension.
Holverda S; Bogaard HJ; Groepenhoff H; Postmus PE; Boonstra A; Vonk-Noordegraaf A
Respiration; 2008; 76(2):160-7. PubMed ID: 17960052
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary hypertension in chronic obstructive and interstitial lung diseases.
Andersen CU; Mellemkjær S; Nielsen-Kudsk JE; Bendstrup E; Hilberg O; Simonsen U
Int J Cardiol; 2013 Oct; 168(3):1795-804. PubMed ID: 23849967
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary hypertension in interstitial lung disease.
Behr J; Ryu JH
Eur Respir J; 2008 Jun; 31(6):1357-67. PubMed ID: 18515559
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary hypertension in interstitial lung disease.
Polomis D; Runo JR; Meyer KC
Curr Opin Pulm Med; 2008 Sep; 14(5):462-9. PubMed ID: 18664977
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary hypertension complicating interstitial lung disease and COPD.
Shino MY; Lynch JP; Saggar R; Abtin F; Belperio JA; Saggar R
Semin Respir Crit Care Med; 2013 Oct; 34(5):600-19. PubMed ID: 24037628
[TBL] [Abstract][Full Text] [Related]
17. A potential role for sildenafil in the management of pulmonary hypertension in patients with parenchymal lung disease.
Madden BP; Allenby M; Loke TK; Sheth A
Vascul Pharmacol; 2006 May; 44(5):372-6. PubMed ID: 16574495
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary hypertension associated with chronic obstructive pulmonary disease.
Chhabra SK
Indian J Chest Dis Allied Sci; 2010; 52(1):29-40. PubMed ID: 20364612
[TBL] [Abstract][Full Text] [Related]
19. Increased plasma levels of adrenomedullin, a vasoactive peptide, in patients with end-stage pulmonary disease.
Vizza CD; Letizia C; Sciomer S; Naeije R; Della Rocca G; Di Roma A; Musarò S; Quattrucci S; Gaudio C; Battagliese A; Badagliacca R; D'Erasmo E; Fedele F
Regul Pept; 2005 Jan; 124(1-3):187-93. PubMed ID: 15544858
[TBL] [Abstract][Full Text] [Related]
20. Sarcoidosis-associated pulmonary hypertension: assessment and management.
Palmero V; Sulica R
Semin Respir Crit Care Med; 2010 Aug; 31(4):494-500. PubMed ID: 20665399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
